Vertex Pharmaceuticals

Results: 56



#Item
1Media release as of April 17, 2015  Interim report of BB Biotech AG as of March 31, 2015 Biotech sector continues to outperform – strengthened balance sheets will sustain the industry’s solid growth

Media release as of April 17, 2015 Interim report of BB Biotech AG as of March 31, 2015 Biotech sector continues to outperform – strengthened balance sheets will sustain the industry’s solid growth

Add to Reading List

Source URL: www.bellevue.ch

Language: English - Date: 2015-04-16 10:43:32
2

PDF Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-23 21:11:42
3

PDF Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:15
43 NOVEMBER 2011 MEDIA RELEASE Groundbreaking Cystic Fibrosis Study Brings Researchers Closer to Finding a Cure A revolutionary new treatment for Cystic Fibrosis (CF) has been uncovered during a groundbreaking study invol

3 NOVEMBER 2011 MEDIA RELEASE Groundbreaking Cystic Fibrosis Study Brings Researchers Closer to Finding a Cure A revolutionary new treatment for Cystic Fibrosis (CF) has been uncovered during a groundbreaking study invol

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2013-02-27 20:02:41
5Chapter Chat  W I N T E R

Chapter Chat W I N T E R

Add to Reading List

Source URL: www.cff.org

Language: English - Date: 2012-02-01 17:31:42
6Microsoft Word - Document1

Microsoft Word - Document1

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2013-02-27 19:54:31
7FDA questions benefit of cystic fibrosis drug from Vertex (Update)

FDA questions benefit of cystic fibrosis drug from Vertex (Update)

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-05-18 04:50:25
8Clinical Commissioning Policy: Ivacaftor for Cystic Fibrosis (G551D mutation) Reference: NHS England A01/P/a 1

Clinical Commissioning Policy: Ivacaftor for Cystic Fibrosis (G551D mutation) Reference: NHS England A01/P/a 1

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2015-01-14 05:46:19
9Ivacaftor / Phenols / Quinolones / Cystic fibrosis / Vertex Pharmaceuticals / Clinical trial / VX-809 / Health / Medicine / Anilides

6.11 IVACAFTOR Tablet; 150 mg; Kalydeco®; Vertex Pharmaceuticals (Australia) Pty Ltd. Purpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:15
10Vertex’s response to the Public Consultation on the Postmarket Review of the Life Saving Drugs Programme Executive Summary In this submission, we set out Vertex’s response to the Post-Market Review of the Life Saving

Vertex’s response to the Public Consultation on the Postmarket Review of the Life Saving Drugs Programme Executive Summary In this submission, we set out Vertex’s response to the Post-Market Review of the Life Saving

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-04-10 00:39:25